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The regulation of innate immune responses to pathogens occurs through the interaction of Toll-like recep-
tors (TLRs) with pathogen-associated molecular patterns and the activation of several signaling pathways
whose contribution to the overall innate immune response to pathogens is poorly understood. We demonstrate
a mechanism of control of murine macrophage responses mediated by TLR1/2 heterodimers through c-Jun
N-terminal kinase 1 (JNK1) activity. JNK controls tumor necrosis factor alpha production and TLR-mediated
macrophage responses to Borrelia burgdorferi, the causative agent of Lyme disease, and the TLR1/TLR2-specific
agonist PAM3CSK4. JNK1, but not JNK2, activity regulates the expression of the tlr1 gene in the macrophage
cell line RAW264.7, as well as in primary CD11b cells. We also show that the proximal promoter region of
the human tlr1 gene contains an AP-1 binding site that is subjected to regulation by the kinase and binds two
complexes that involve the JNK substrates c-Jun, JunD, and ATF-2. These results demonstrate that JNK1
regulates the response to TLR1/2 ligands and suggest a positive feedback loop that may serve to increase the
innate immune response to the spirochete.
Toll-like receptors (TLRs) play critical roles during the ini-
tiation of innate immunity and the development of specific
cell-mediated immune responses (1). The members of the
TLR family recognize specific components conserved among
microorganisms (1), such as triacylated antigens of Borrelia
burgdorferi, the causative agent of Lyme disease (2). In hu-
mans, the levels of expression of TLR1 have been involved in
their capacity to respond to lipidated OspA (2), the antigen
used for the FDA-approved vaccine against Lyme borreliosis
that has been retired from the market. Similarly, the capacity
of B. burgdorferi to induce proinflammatory cytokine produc-
tion is associated with the interaction of lipoproteins of the
spirochete with TLR1/TLR2 complexes (2, 16). The compari-
son of disease in patients with polymorphic forms of different
TLRs has demonstrated their importance in the progression of
asthma and atherosclerosis (13, 25). TLR expression is regu-
lated by their interaction with specific ligands and by cytokines.
Thus, during leprosy, TLR1 expression is upregulated by
gamma interferon (IFN-) (20), while B. burgdorferi lipopro-
teins increase the expression of TLR1 and TLR2 and induce
the downregulation of TLR5 (7). Lipopolysaccharide has also
been shown to induce increased expression of TLRs and ac-
cessory molecules, including MyD88 and MD-2 (24, 29). The
mechanism by which this regulation occurs is not completely
understood. The transcription factors AP-1, Ets, and PU.1
have been involved in the regulation of murine TLR4 expres-
sion (28, 34).
The interaction of TLRs with specific ligands results in the
activation of several signaling pathways. The activation of the
transcription factor NF-B in response to TLR stimulation
results in the expression of chemotactic factors, proinflamma-
tory cytokines, and adhesion molecules in several cell types,
such as macrophages, fibroblasts, and synovial cells (19). TLR
engagement also results in the activation of the mitogen-acti-
vated protein p38 and c-Jun N-terminal kinases (JNK) (19).
These pathways are involved in various physiological pro-
cesses. The JNK pathway regulates apoptosis, development,
cell transformation, T-cell activation and differentiation, and
cytokine production (10, 18, 31, 33, 35, 38, 39). Three isoforms
of JNK have been identified: two ubiquitously expressed iso-
forms, JNK1 and JNK2, and the tissue-specific isoform JNK3
(9). JNK phosphorylates the transcription factor c-Jun and
increases AP-1 transcriptional activity. Other substrates in-
clude JunD, ATF-2, ATF-a, Elk-1, Sap-1, and NFATc3 (9).
In this study, we show that JNK1 controls macrophage re-
sponses to B. burgdorferi by regulating the expression of the tlr1
gene. Our results clarify the role of this kinase in the innate
immune response to B. burgdorferi.
MATERIALS AND METHODS
Cells. JNK1-deficient (10) and JNK2-deficient (41) C57BL/6 (B6) mice were
used to purify splenic macrophages by positive selection, using a biotinylated
antibody (Ab) against CD11b (BD Pharmingen, La Jolla, CA). The purity of the
cells, as determined by flow cytometry, was 85%. The macrophage cell line
RAW264.7 (ATCC, Manassas, VA) was grown in RPMI medium (Sigma, St.
Louis, MO) supplemented with 10% fetal calf serum.
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All procedures that involved animals were in accordance with institutional
guidelines for animal care at UNC Charlotte and the University of Massachusetts
at Amherst.
Plasmids, small interfering RNA (siRNA), and transfections. Plasmids con-
taining a mutant (dominant-negative) version of human JNK1 (dnJNK), con-
structed by replacement of Thr183 and Tyr185 by Ala and Phe, respectively (27),
or the luciferase gene downstream of 2AP-1 (27) or 5NF-B (Stratagene, La
Jolla, CA) response elements were used. The plasmids were transfected into 3 
106 to 5  106 RAW264.7 cells using DEAE-Dextran (Promega, Madison, WI)
according to the manufacturer’s protocol. The plasmid pBluescript SK() (SK)
was used as a negative control in transfections with the plasmid containing
dnJNK.
siRNA targeting jnk1 mRNA (Ambion, Austin, TX) was used to transfect 5 
105 RAW264.7 cells using the siPort Amine transfection agent (Ambion) fol-
lowing the manufacturer’s instructions. Control siRNA (Ambion) containing a
random mixture of oligonucleotides was used in parallel. After 48 h, the cells
were assessed for jnk1 mRNA by reverse transcriptase (RT) PCR (Table 1) and
stimulated as described below.
Stimulations. Low-passage B. burgdorferi N40 lysates were obtained from
mid-log phase cultures by sonication. The protein concentration was determined
by the Bradford method (Bio-Rad, Hercules, CA). The TRL1/TLR2 agonist
N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-Cys-[S]-Ser-[S]-Lys4 trihydro-
chloride (PAM3-CSK4) was purchased from Invivogen (San Diego, CA). In vitro
stimulations were performed using 10 g/ml of B. burgdorferi lysate or 1 g/ml of
PAM3-CSK4.
The phosphorylation of STAT-1 in response to IFN- stimulation of
RAW264.7 cells was determined by stimulation with 100 ng/ml of recombinant
murine IFN- (R&D Systems, Minneapolis, MN) for 30 min. Phospho-Tyr701
and total STAT1 (Cell Signaling, Danvers, MA) were then detected by immu-
noblotting.
JNK activity determination. Five million RAW264.7 or primary CD11b cells
were incubated with 10 g/ml of a B. burgdorferi lysate for the indicated times.
The cells were washed and lysed, and JNK activity was determined using the JNK
activity assay kit (Cell Signaling) according to the manufacturer’s protocol.
Briefly, JNK was immunoprecipitated from the stimulated cell extracts with a
c-Jun fusion protein bound to agarose. The immunoprecipitate was incubated in
kinase buffer for 30 min at 30°C. Phospho-c-Jun was then detected by immuno-
blotting using a rabbit phospho-c-Jun polyclonal Ab.
Cytokine ELISA. The levels of tumor necrosis factor alpha (TNF-) produced
by B. burgdorferi-stimulated primary CD11b and RAW264.7 cells were deter-
mined by capture enzyme-linked immunosorbent assay (ELISA), as described
previously (3).
Abs and Western blotting. Anti-IB (Santa Cruz Biotechnology), anti-TLR1,
and anti-TLR2 (Invivogen) Abs were used. Immunoblotting was performed with
stimulated and unstimulated cell extracts, using standard protocols.
RT-PCR. Total RNA was isolated from splenic purified CD11b and
RAW264.7 cells using the TRIzol reagent (Invitrogen, Carlsbad, CA) according
to the instructions of the manufacturer. PCR was performed to determine the
expression of tlr1, tlr2, and the glyceraldehyde-3-phosphate dehydrogenase gene
(gapdh) using 95°C denaturation, 55°C (tlr1 and tlr2) or 60°C (gapdh) annealing,
and 72°C extension temperatures with the primers listed in Table 1.
Real-time RT-PCR to quantify tlr1 and tlr2 gene expression in dnJNK-trans-
fected cells was performed using the primers listed in Table 1 and 2 l of cDNA
in a final volume of 20 l. The reaction mixture contained SYBR green (Quanta
Biosciences, Gaithersburg, MD) and ROX (as a reference dye). The reaction was
performed at an annealing temperature of 55°C. Relative expression of the gene
was determined by amplifying 	-actin (Applied Biosystems, Foster City, CA)
and was referred to control (SK)-transfected cells, according to the following
formula:
Induction (n-fold) 
 2[(C
Ttlr1  CTactin)dnJNK  (C
Ttlr1  CTactin)SK]
where CT represents the threshold cycle for each gene.
Construction of tlr1-luc and tlr1(mut)-luc plasmids. The proximal DNA frag-
ment corresponding to 1 kb of the human tlr1 gene promoter region was sub-
cloned upstream of the promoterless firefly luciferase (luc) gene in the vector
pGL3-basic (Promega). The 1-kb promoter fragment was generated by PCR
(Table 1) using genomic DNA isolated from HeLa cells as a template. The
fragment was cloned into the pBAD-TOPO (Invitrogen) vector and subcloned
using the SmaI and SacI restriction sites into the pGL3 vector (pGL3-tlr1-luc).
The construct was sequenced across both junctions to confirm the nucleotide
sequence and the predicted orientation. Empty pGL3 was used as a control.
The pGL3-tlr1(mut)-luc plasmid, a derivative of pGL3-tlr1-luc with the AP-1-
binding site deleted (nucleotides 502 to 508 relative to the transcription start
site), was constructed by using the QuikChange II XL site-directed mutagenesis
kit (Stratagene) according to the manufacturer’s instructions. The primers used
for the deletion of the 7 bp are listed in Table 1. The mutations were confirmed
by sequencing.
Nuclear extracts and electromobility shift assay (EMSA). Mini nuclear ex-
tracts were obtained as described previously (26) from 106 RAW264.7 cells
unstimulated or stimulated with 10 g/ml of a B. burgdorferi lysate for 16 h.
Binding reactions were performed using 2 g of nuclear protein in the presence
of a specific 32P end-labeled double-stranded oligonucleotide as described pre-
viously (26) in the absence or presence of unlabeled oligonucleotides. The
oligonucleotides used in this study are listed in Table 1. Supershift/competition
assays were performed using 1 l of anti-c-Jun (N), c-Fos (4), JunD (329), ATF-2
(C-19), and CREB (H-74) Abs (Santa Cruz Biotechnology).
Statistical analyses. Data are presented as the means and standard errors of
at least three independent experiments or means and standard deviations for
experiments performed in triplicate. The means of independent experiments
were compared with two-way analysis of variance, followed by Bonferroni post-
TABLE 1. Primers used in the study
Gene/target Sequencea Purpose
tlr1 5-CGC AAA CCT TAC CAG AGT G-3 RT-PCR
5-GAC TGG CGT ATG CCA AAC TA-3
tlr1 5-CTG GAG TCT GTT GTA GGA C-3 Real-time PCR
5-GAC TGG CGT ATG CCA AAC TA-3
tlr2 5-AAG TGA AGA GTC AGG TGA TGG ATG TCG-3 RT-PCR
5-GCA GAA TCA ATA CAA TAG AGG GAG ACG C-3 Real-time PCR
jnk1 5-TGT GGA ATC AAG CAC CTT CAC TCT GCT G-3 RT-PCR
5-GCA AAC CAT TTC TCC CAT AAT GCA CCC-3
gadph 5-CCA TCA CCA TCT TCC AGG AGC GAG-3 RT-PCR
5-CAC AGT CTT CTG GGT GGC AGT GAT-3
tlr1 promoter 5-AAG AGC TCC TGA GGT AAG GGG AAA CAG AG-3 PCR
5-AAC CCG GGA AGA AAT TCA AGC ACT TCC TTG-3
tlr1 promoter 5-AAT CAA CTT GTC AAA AAA GAC GCA TCC ATC
CTG TAA CCA GCA CA-3
Site-directed
mutagenesis
5-TGT GCT GGT TAC AGG ATG GAT GCG TCT TTT
TTG ACA AGT TGA TT-3
tlr1-AP-1 (230, 236) 5-TAG TAA ACT GAC TGT AGT GA-3 EMSA
tlr1-AP-1 (471, 480) 5-GCA CAT GAA TGA TCT TCC CT-3 EMSA
tlr1-AP-1 (502, 508) 5-AAA GAC GTG ATT AAC ATC CAT-3 EMSA
AP-1 consensus 5-CGC TTG ATG ACT CAG CCG GAA-3 EMSA
a Underlining represents the consensus sequence.
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tests, using the software Prism version 4.0. The means were considered statisti-
cally different when P was 0.05.
RESULTS
JNK activity regulates TNF- production in response to B.
burgdorferi. The role played by the JNK pathway in macro-
phage responses to pathogens mediated by TLRs is poorly
understood. To address whether the interaction between B.
burgdorferi antigens and macrophages results in the activation
of JNK, we first stimulated RAW264.7 cells with a B. burgdor-
feri lysate. JNK activity was evident after 40 min of stimulation
and decayed after 80 min (Fig. 1A). The activation of JNK was
also detected in primary splenic macrophages (CD11b cells)
from B6 mice stimulated with a B. burgdorferi lysate (Fig. 1A).
The involvement of JNK activity in macrophage responses to
TLR ligands was then assessed. RAW264.7 cells were trans-
fected with a dominant-negative form of the kinase (dnJNK)
(27) and stimulated with a B. burgdorferi lysate or the TLR1/
TLR2 agonist PAM3-CSK4, and the supernatants were evalu-
ated for TNF- production. The repression of JNK activity
resulted in a significant reduction of TNF- production com-
pared to control transfected cells (P  0.001 for B. burgdorferi
FIG. 1. JNK activity regulates TNF- production in response to B.
burgdorferi. (A) RAW264.7 (top) and primary CD11b (bottom) cells
were stimulated with a B. burgdorferi lysate for the indicated times
(top) or 40 min (bottom) prior to assaying JNK activity in vitro with
c-Jun as a substrate. Phospho-c-Jun was then detected by immunoblot-
ting. The results are representative of three experiments performed.
(B) RAW264.7 cells were transfected with a plasmid containing
dnJNK1 or a plasmid control (SK) and stimulated with a B. burgdorferi
lysate (Bb) or PAM3-CSK4 for 16 h. The TNF- levels in the stimu-
lation supernatants were then quantified by ELISA. The results shown
are the average plus standard error (SE) of three independent exper-
iments. *, P  0.001 and P  0.01 for B. burgdorferi and PAM3-CSK4
stimulation, respectively. (C) RAW264 cells were stimulated with 10
g/ml of a B. burgdorferi lysate (Bb) or 1 g/ml of PAM3-CSK4 in the
presence of increasing concentrations of the JNK inhibitor SP100625.
TNF- was quantified in the stimulation supernatants after 16 h. The
results are the average plus SE of three independent experiments.
FIG. 2. TLR1/2-mediated responses are dependent on JNK activ-
ity. (A) RAW264.7 cells were cotransfected with a plasmid containing
the luciferase gene under the influence of AP-1 (A) or NF-B (B) re-
sponse elements plus a plasmid containing the dnJNK form or a
plasmid control (SK). The cells were then stimulated with a B. burg-
dorferi lysate (Bb) for 16 h, and luciferase activity was assayed. The
results shown are the average  standard error of four and three
independent experiments, respectively. *, P  0.001 (AP-1-luc) and
P  0.05 (NF-B-luc). (C) RAW264.7 cells were transfected with a
plasmid containing the dnJNK form or a plasmid control (SK) and
stimulated with a B. burgdorferi lysate for the indicated times. The cells
were then lysed and assessed for IB content by immunoblotting
(left). Band quantitation was performed with the Java-based software
ImageJ (right). The experiment shown is representative of three per-
formed. (D) RAW264.7 cells were transfected with a plasmid contain-
ing the dnJNK form or a plasmid control (SK) and stimulated with
recombinant murine IFN- for 30 min. Phospho-STAT1 and total
STAT-1 levels were determined by immunoblotting. The results shown
are representative of two experiments performed with similar results.
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and P  0.01 for PAM3-CSK4 stimulation) (Fig. 1B). Similar
results were obtained in macrophages isolated from the
spleens of B6 mice (data not shown) and RAW264.7 cells
stimulated with a B. burgdorferi extract or PAM3-CSK4 in the
presence of increasing concentrations of the JNK inhibitor
SP600125 (5) (Fig. 1C). The reduced production of TNF- was
not the result of SP600125-induced cell death, as determined
by the analysis of the cells by trypan blue exclusion (data not
shown). These results indicated that TLR1/TLR2-mediated
TNF- production in macrophages involves JNK activity.
TLR-mediated responses are dependent on JNK activity.
We further substantiated the contribution of JNK activity to
TLR-induced signaling events in macrophages by analyzing
the activation of JNK-dependent and independent tran-
scription factors. JNK activity results in the phosphorylation
of c-Jun and the formation of AP-1 complexes (9). As ex-
pected, the repression of JNK activity during stimulation
with B. burgdorferi resulted in decreased AP-1 transcrip-
tional activity (P  0.001) (Fig. 2A). As a control, we also
analyzed the activation of JNK-independent signaling path-
ways in response to B. burgdorferi antigens. Surprisingly, the
repression of JNK activity also resulted in reduced NF-B
transcriptional activity (P  0.05) (Fig. 2B). No reports have
associated JNK activity and the activation of NF-B. Since
the repression of JNK activity during stimulation with TLR
ligands results in lower TNF- production, and this cytokine
also activates NF-B (36), we analyzed IB degradation in
the cells that had been transfected with the dnJNK plasmid
at times when the production of the cytokine was not evi-
dent (data not shown). The stimulation of RAW264.7 cells
transfected with the dnJNK plasmid also resulted in de-
creased degradation of IB (Fig. 2C), suggesting that the
inhibition of JNK results in decreased activation of NF-B.
In order to assess whether the repression of JNK in macro-
phages results in both TLR-dependent and -independent
cell responses, we determined the effect of JNK repression
in response to IFN--induced signals. The phosphorylation
of STAT1 induced by IFN- was not affected by the pres-
ence of the dnJNK-containing plasmid in RAW264.7 cells
(Fig. 2D), indicating that JNK affects TLR-mediated re-
FIG. 3. JNK1 regulates the expression of the tlr1 gene. (A) (Left) RAW264.7 cells were transfected with a plasmid containing a dnJNK form
or a plasmid control (SK), and total RNA was extracted and assessed by RT-PCR (left) or real-time RT-PCR (right) for the expression of tlr1 and
tlr2 mRNAs. Equal input of RNA (left) was assessed by the amplification of the housekeeping gene gapdh. (B) The cells were also used to
determine the levels of TLR1 and TLR2 by Western blotting. Protein input was assessed by immunobloting with an anti-actin Ab. (C) CD11b
cells were purified from B6 (WT) and JNK1- and JNK2-deficient mice. RNA was extracted and subjected to RT-PCR for the expression of tlr1
and tlr2. RNA input was assessed by the amplification of gapdh mRNA. (D) RAW264.7 cells were transfected with JNK1 siRNA or a control (siNC)
and used to extract RNA and to determine the mRNA levels of jnk1, tlr1, and tlr2. Equal input was determined by amplification of gapdh mRNA.
(E) Purified CD11b cells from B6 (WT) and JNK1- and JNK2-deficient mice were unstimulated (Unst.) or stimulated with a B. burgdorferi lysate
(Bb). The levels of TNF- were determined in the stimulation supernatants after 16 h. (F) dnJNK1-transfected RAW264.7 cells were stimulated
with lipopolysaccharide (LPS), poly(dI-dC), and flagellin, and TNF- was detected 16 h later. (G) RAW264.7 cells were transfected with siRNA
oligonucleotides specific for JNK1 or control oligonucleotides (siNC). Forty-eight hours later, the cells were stimulated for 16 h with a B. burgdorferi
lysate (Bb) or PAM3-CSK4 and assessed for TNF- by ELISA. The results represent the average plus standard error (SE) of three independent
experiments. *, P  0.05. (H) RAW264.7 cells were cotransfected with a plasmid encoding TLR1 under the influence of a constitutively expressed
promoter (UNO) or a control plasmid (GL3) plus a plasmid containing the dnJNK form or the empty plasmid (SK). All cells were transfected with
the same amount of plasmid. The cells were then stimulated with a B. burgdorferi lysate (Bb) or PAM3CysK4. TNF- levels in the supernatants
were determined 16 h after stimulation. The results shown represent the average plus SE of three independent experiments. *, P  0.05 compared
to control-, UNO plus control-, or UNO plus dnJNK-transfected cells stimulated with B. burgdorferi and PAM3-CSK4.
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sponses, but not the TLR-independent, IFN--mediated re-
sponse, in macrophages.
JNK1 regulates the expression of the tlr1 gene. Our results
suggested that TLR-mediated responses in macrophages are
dependent on JNK activity. These data could be explained by
a direct effect of JNK activity on the regulation of the expres-
sion of the components involved in the responses, including
TLR1 and TLR2, or signaling intermediates that lead to the
activation of downstream signaling pathways. To test whether
JNK regulates the expression of the components involved in
TLR-mediated responses, we analyzed tlr1 and tlr2 mRNA
levels in macrophages with repressed or absent JNK activity.
RAW264.7 cells transfected with dnJNK showed lower expres-
sion levels of tlr1, with no effect on tlr2 (Fig. 3A). These results
correlated with lower TLR1 protein levels than in control
transfected cells, while TLR2 protein levels were not affected
by the dnJNK plasmid (Fig. 3B). The reduction of TLR1
surface protein expression induced by the repression of JNK
activity was also observed by flow cytometry in THP-1 cells
transfected with dnJNK (data not shown).
To further demonstrate the regulation of tlr1 gene expres-
sion by JNK, we analyzed the levels of expression of both tlr1
and tlr2 genes in primary macrophages from JNK1- and JNK2-
deficient mice. While tlr2 mRNA was not affected by the lack
of either JNK1 or JNK2, tlr1 mRNA was reduced in JNK1-
deficient macrophages (Fig. 3C). Moreover, the silencing of
JNK1-encoding mRNA in RAW264.7 cells resulted in lower
tlr1 gene expression than in controls (Fig. 3D), suggesting that
JNK1 activity specifically regulates the expression of TLR1.
To assess the contribution of the JNK isoforms to TNF-
production in response to B. burgdorferi, we stimulated JNK1-
and JNK2-deficient CD11b cells with a B. burgdorferi lysate.
Both JNK1- and JNK2-deficient macrophages produced lower
levels of TNF- than wild-type macrophages, although the
differences were not statistically significant (Fig. 3E). Corre-
spondingly, JNK1 siRNA-transfected RAW264.7 cells pro-
duced lower levels of TNF- in response to a B. burgdorferi
lysate and PAM3-CSK4 (P  0.05 for both stimuli) (Fig. 3G),
indicating that JNK1 and JNK2 regulate the production of
TNF- through different mechanisms and that it involves the
regulation of tlr1 gene expression by JNK1.
To determine whether JNK1 regulates TLR1/2-mediated
responses solely through the control of TLR1 expression, we
transfected RAW264.7 cells with a plasmid that drove the
constitutive expression of the receptor. The ectopic expression
of TLR1 prevented the inhibition of TNF- production in the
presence of the dnJNK plasmid in response to B. burgdorferi
antigens and PAM3-CSK4 (Fig. 3H), confirming that JNK1
controls TLR1/2-mediated signals in macrophages by regulat-
ing the expression of TLR1.
JNK1 regulates tlr1 promoter activity. To further demon-
strate that JNK activity regulates tlr1 gene transcription, we
cloned the proximal 1-kb promoter region of the tlr1 gene (Fig.
4) upstream of a promoterless luciferase gene. The transfec-
FIG. 4. Structure of the human tlr1 gene. The 1-kb proximal promoter and the gene encoding TLR1 are shown. The proximal promoter
sequence is shown in the magnified box, with the three putative AP-1 binding sites highlighted. The sequence corresponds to nucleotides 5956071
to 5955050 of contig NT016297 (NCBI/NIH).
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tion of RAW264.7 cells with this construct resulted in basal
levels of promoter activity that were significantly enhanced by
the stimulation of the cells (P  0.05) (Fig. 5A). The increased
luciferase expression correlated with augmented TLR1 protein
levels in RAW264.7 cells that had been stimulated with a B.
burgdorferi lysate (Fig. 5A). The cotransfection of RAW264.7
cells with this plasmid and the dnJNK-containing plasmid re-
sulted in the repression of promoter activity (P  0.001 for all
three conditions) (Fig. 5A), confirming that JNK is involved in
the regulation of TLR1 expression.
Three putative AP-1 binding sites that potentially could serve
as AP-1 binding sites in the tlr1 promoter were identified (Fig. 4).
Double-stranded oligonucleotides that spanned these regions
were used in EMSAs (Table 1). Only the oligonucleotide based
on the sequence found at 502 to 508 showed binding of
nuclear extract preparations of unstimulated (Fig. 5B) and B.
burgdorferi-stimulated (not shown) RAW264.7 cells. We observed
two binding complexes at this site. The lower complex increased
in B. burgdorferi-stimulated RAW264.7 compared to unstimu-
lated cells (Fig. 5C) and was competed when the binding reac-
tions contained anti-c-Jun and anti-c-Fos Abs (Fig. 5C). This
complex was competed by unlabeled double-stranded oligonucle-
otides corresponding to the AP-1 consensus binding site (Fig. 5C)
and coincided with the complex obtained with a consensus AP-1
binding site oligonucleotide (Fig. 5D). The presence of ATF-2
and JunD Abs competed the formation of both complexes, while
Abs to CREB did not result in competition (Fig. 5C). The upper
band observed with anti-CREB was not consistently seen in other
experiments performed. These results suggested that this region
serves as a docking area for two complexes that contain ATF-2
plus JunD and c-Jun plus c-Fos. These data also suggested that
the upper complex is involved in the constitutive expression of the
tlr1 gene while the lower complex is formed in response to stim-
ulation with B. burgdorferi antigens. Since ATF-2 and JunD are
substrates of JNK (12), this interpretation is in agreement with
the control of basal levels of tlr1 gene expression by JNK. Overall,
these data demonstrated the presence of functional AP-1 binding
sites in the proximal promoter region of the tlr1 promoter.
The contribution of the 502 to 508 binding site to the
regulation of tlr1 gene expression mediated by JNK was tested
with a deletion mutant of the tlr1-luc construct. The deletion
resulted in decreased promoter activity that was not enhanced
by stimulation with a B. burgdorferi lysate or PAM3-CSK4 (P 
0.05 for both stimuli) (Fig. 5E). Furthermore, compared to the
wild-type promoter, the mutated form was not affected by the
coexpression of dnJNK (Fig. 5E). Overall, these data demon-
strate that JNK1 activity regulates the expression of TLR1 in
macrophages.
DISCUSSION
The interaction of pathogen-associated molecular patterns
with the germ line-encoded TLRs is a fundamental feature of
the immune response associated with infection. It is becoming
evident that these interactions in innate immune cells have
profound consequences for the ability of the body to mount
efficient or detrimental responses to pathogens. Thus, deficien-
cies in TLR1, TLR2, or the adaptor protein MyD88 lead to
increased B. burgdorferi burdens in mice (2, 4, 6, 21, 40), un-
derscoring the importance of these receptors for the efficient
FIG. 5. JNK1 regulates tlr1 promoter activity. (A) (Top) RAW264.7 cells
were cotransfected with a plasmid containing the luciferase gene downstream
of the 1-kb proximal tlr1 promoter and the dnJNK plasmid or a plasmid
control (SK) and stimulated with a B. burgdorferi lysate (Bb) or PAM3-CSK4
or left unstimulated (Unst.). Luciferase activity (AU, arbitrary units) was
measured after 16 h of stimulation. The data presented correspond to the
average plus standard deviation of triplicate determinations of one of four
experiments performed. *, P  0.05. (Bottom) Western blot of RAW264.7
cells stimulated with 10 g/ml of a B. burgdorferi lysate for 16 h using anti-
TLR1 Ab. Equal protein input was assessed with anti-Actin Ab. (B) EMSA
showing nuclear extract binding to oligonucleotides (oligo) containing puta-
tive AP-1 binding sites in the proximal 1-kb tlr1 promoter. The reactions were
performed in the absence or presence of an excess (100) of unlabeled (cold)
oligonucleotides. (C) EMSA of nuclear extracts of RAW264.7 cells unstimu-
lated and stimulated with a B. burgdorferi lysate for 30 min. The reactions
were performed in the absence or the presence of Abs against c-Jun, JunD,
c-Fos, CREB, and ATF-2 and in the absence or presence of unlabeled (cold)
oligonucleotides corresponding to the tlr1 promoter or the AP-1 consensus
binding sequence. The arrows indicate the constitutive (top) and B. burgdor-
feri-enhanced (bottom) complexes formed. (D) EMSA of tlr1-derived and
consensus AP-1 binding oligonucleotides with nuclear extracts from unstimu-
lated or B. burgdorferi-stimulated RAW264.7 cells. (E) RAW264.7 cells were
cotransfected with plasmids containing tlr1- or tlr1(502,508) [tlr1(mut)]-
luciferase and a plasmid containing dnJNK or a plasmid control (SK). After
48 h, the cells were stimulated with aB. burgdorferi lysate (Bb) or PAM3-CSK4
or left unstimulated (Unst.). Luciferase activity was measured 16 h poststimu-
lation. The results shown are the average plus standard error of three inde-
pendent experiments. *, P  0.05.
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control of infection. Moreover, the severity of pathology asso-
ciated with infection with Mycobacterium leprae is associated
with the host’s capacity to respond to mycobacterial antigens
and is also related to TLR expression (20). In addition, TLR
ligands are being considered as potential adjuvants that could
help boost the response to vaccines compared to the currently
limited choices in humans (17, 32). TLR-mediated signals are
also required for the successful vaccination of individuals
against infectious diseases. For example, the deficient expres-
sion of TLR1 in patients hyporesponsive to lipidated outer
surface protein A of B. burgdorferi is associated with decreased
responses to the vaccine against the spirochete (2). It is there-
fore imperative to understand the control of these responses,
including how the expression of TLRs is regulated in innate
immune cells.
Our results demonstrate that JNK activation upon engage-
ment of TLR1/2 complexes with specific ligands initiates a
positive feedback cascade that increases the expression of
TLR1. They also show that in our model the ectopic expression
of the receptor restores the capacity of macrophages to re-
spond to B. burgdorferi and PAM3-CSK4, indicating that in our
system, JNK1 activity contributes exclusively to TLR1 expres-
sion. Experiments with splenic macrophages derived from de-
ficient mice demonstrated that JNK1, but not JNK2, activity is
involved in the control of TLR1 expression, while neither
JNK1 nor JNK2 regulates the expression of TLR2 in
RAW264.7 cells or primary macrophages. These results corre-
late with previous observations in the macrophage cell line
RAW264.7 that showed no implication of JNK in the expres-
sion of the tlr2 gene (22). Furthermore, our results show that
JNK2 also contributes to the induction of TNF- in response
to B. burgdorferi antigens and the TLR1/2 agonist PAM3-CSK4
through a mechanism that does not involve the regulation of
TLR1. In correlation, the induction of TNF- by the TLR4,
TLR9, and TLR5 agonists lipopolysaccharide, poly(dI-dC),
and flagellin, respectively, was lowered in cells transfected with
the plasmid containing dnJNK (Fig. 3F). These data therefore
imply nonoverlapping functions of the two kinases that have
also been demonstrated in T cells and other cell types (8, 10,
30, 41) and that have been associated with differential binding
of both isoforms with their substrates (11).
Several reports have shown the regulation of TLR expres-
sion by different stimuli, including B. burgdorferi stimulation
and cytokines (7, 20, 24). Similarly, corticotropin-releasing fac-
tor and the urocortins regulate the expression of TLR4
through the activation of the transcription factors PU.1 and
AP-1 (34), although the exact mechanisms of regulation have
not been described. The regulation of TLR expression may be
stimulus dependent, since B. burgdorferi does not affect the
expression of the tlr4 gene (reference 7 and data not shown).
Similarly, the regulation of tlr2 gene expression by NF-B has
been documented (22–24), and NF-B binding sites have been
described in the tlr2 promoter (23, 37). However, our results
indicate that despite lower NF-B activation induced by TLR
ligands in the absence of JNK activity due to reduced expres-
sion levels of TLR1, the levels of TLR2 remained unchanged.
The interaction of B. burgdorferi antigens with macrophages
potentially occurs through different TLRs: TLR1/TLR2 dimers
respond to triacylated lipoproteins, such as lipidated OspA (2),
while TLR5 and TLR9 probably contribute to the response of
bacterial lysates through their interaction with flagellin and
hypomethylated CpG motifs, respectively (14, 15). In turn,
these interactions may be physiologically relevant, due to bac-
terial death in vivo. Our results strongly suggest, however, that
the predominant response under our experimental conditions
occurred through TLR1/TLR2, since (i) the response was
mimicked by the use of the TLR1/TLR2 agonist PAM3-CSK4
and (ii) the ectopic expression of TLR1 in JNK-repressed
RAW264.7 cells completely restored the responses to both B.
burgdorferi extracts and PAM3-CSK4. In light of our results, we
propose that the interactions of spirochetal antigens with
TLRs result in the activation of JNK. JNK substrates contrib-
ute to the upregulation of the tlr1 gene, which in turn increases
the response of macrophages to TLR1/TLR2 ligands. Thus, we
propose that JNK1 contributes to the response of macrophages
to B. burgdorferi by regulating the expression of TLR1.
Several signaling pathways are activated as a result of the
ligation of TLRs with specific ligands. The specific contribution
of each pathway to phagocytic responses is still unclear. During
infection with B. burgdorferi, p38 mitogen-activated protein
kinase controls inflammation (3). Our results indicate that the
different signal pathways activated as a result of the interac-
tions between TLRs and their ligands are not redundant, al-
though they may all be needed for a full response to infectious
agents. Since macrophage responses to B. burgdorferi are
largely dependent on TLR-mediated interaction with ligands
present in the bacterium, our results can provide the basis for
a full understanding of the immune response to this prevalent
infectious agent.
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